Treatment increased in anti-inflammatory cells CD4+ T regulatory (Tregs) and CD4+ IL-10+, induced a decrease in pro-inflammatory cells T helper (Th)1 and Th17, leading to a deceleration of colorectal cancer growth [43]. The gene discussed is CD4; the disease is colorectal cancer.